Effect of Losartan on Right Ventricular Dysfunction Results From the Double-Blind, Randomized REDEFINE Trial (Right Ventricular Dysfunction in Tetralogy of Fallot: Inhibition of the Renin-Angiotensin-Aldosterone System) in Adults With Repaired Tetralogy of Fallot

Author(s):
Bokma, J.P.; Winter, M.M.; Dijk, A.P. van; Vliegen, H.W.; Melle, J.P. van; Meijboom, F.J.; Post, M.C.; Berbee, J.K.; Boekholdt, S.M.; Groenink, M.; Zwinderman, A.H.; Mulder, B.J.M.; Bouma, B.J.
Published
2018
Publication type
Article / Letter to editor
heart defects, congenitalheart failurelosartansurvivaltetralogy of Fallot
Date issued
2018-04-03
Language
English
Is part of
Circulation (2018), Vol. 137, no. 14, p. 1463-1471
hdl
1887/94601
doi
10.1161/CIRCULATIONAHA.117.031438